These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18615244)

  • 1. Determining MHC restriction of T-cell responses.
    Larché M
    Methods Mol Med; 2008; 138():57-72. PubMed ID: 18615244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular basis for detection of infectious agents].
    Siegrist CA
    Schweiz Med Wochenschr; 1996 Feb; 126(7):246-54. PubMed ID: 8720322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Migration inhibition factor secreting human T-cell lines reactive to PPD: a study of their antigen specificity, MHC restriction and the use of Epstein-Barr virus-transformed B-cell lines as requirement for antigen-presenting cells.
    Vyakarnam A; Lachmann PJ
    Immunology; 1984 Dec; 53(4):601-10. PubMed ID: 6209204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hybrid cells formed by fusion of Epstein-Barr virus-associated B-lymphoblastoid cells and either marrow-derived or solid tumour-derived cell lines display different co-stimulatory phenotypes and abilities to activate allogeneic T-cell responses in vitro.
    Cywinski AL; Dunnion DJ; Teobald I; Tucker VC; Browning MJ
    Tissue Antigens; 2006 Aug; 68(2):115-26. PubMed ID: 16866881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial triggering of many T-cell receptors by a few peptide-MHC complexes.
    Valitutti S; Müller S; Cella M; Padovan E; Lanzavecchia A
    Nature; 1995 May; 375(6527):148-51. PubMed ID: 7753171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective functional depletion of HIV gp120 peptides complexed with MHC from antigen-presenting cells engaged with specific T lymphocytes.
    Manca F
    J Immunol; 1992 Aug; 149(3):796-800. PubMed ID: 1634769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-canonical anchor motif peptides bound to MHC class I induce cellular responses.
    Lazoura E; Lodding J; Farrugia W; Day S; Ramsland PA; Apostolopoulos V
    Mol Immunol; 2009 Mar; 46(6):1171-8. PubMed ID: 19118903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [HLA-peptide complex and immunity-related diseases].
    Matsushita S
    Rinsho Byori; 1999 Jun; 47(6):511-8. PubMed ID: 10434567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A reliable and safe T cell repertoire based on low-affinity T cell receptors.
    Van Den Berg HA; Rand DA; Burroughs NJ
    J Theor Biol; 2001 Apr; 209(4):465-86. PubMed ID: 11319895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide.
    Tynan FE; Burrows SR; Buckle AM; Clements CS; Borg NA; Miles JJ; Beddoe T; Whisstock JC; Wilce MC; Silins SL; Burrows JM; Kjer-Nielsen L; Kostenko L; Purcell AW; McCluskey J; Rossjohn J
    Nat Immunol; 2005 Nov; 6(11):1114-22. PubMed ID: 16186824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting virus entry and membrane fusion through specific peptide/MHC complexes using a high-affinity T-cell receptor.
    Peng KW; Holler PD; Orr BA; Kranz DM; Russell SJ
    Gene Ther; 2004 Aug; 11(15):1234-9. PubMed ID: 15215883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degenerate T-cell receptor recognition, autoreactive cells, and the autoimmune response in multiple sclerosis.
    Markovic-Plese S
    Neuroscientist; 2009 Jun; 15(3):225-31. PubMed ID: 19297658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Discovery of MHC restriction in antigen recognition of T cells].
    Lan GT; Zhu LP; Zhang W
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Oct; 24(5):539-41. PubMed ID: 12905783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MHC restriction and allogeneic immune responses.
    Kazansky DB
    J Immunotoxicol; 2008 Oct; 5(4):369-84. PubMed ID: 19404871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to major histocompatibility complex class II inhibit proliferation, but increase production of soluble CD23 in lymphoblastoid B-cell lines.
    Hajeer AH; Snowden N; Wilson P; Drover S; Ollier WE
    Immunology; 1993 Dec; 80(4):593-7. PubMed ID: 8307609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for a major histocompatibility complex class Ib-restricted T cell response.
    Hoare HL; Sullivan LC; Pietra G; Clements CS; Lee EJ; Ely LK; Beddoe T; Falco M; Kjer-Nielsen L; Reid HH; McCluskey J; Moretta L; Rossjohn J; Brooks AG
    Nat Immunol; 2006 Mar; 7(3):256-64. PubMed ID: 16474394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for preferred MHC class II-TCR recognition independent of the source of bound peptide.
    Battaglia M; Gorski J
    Eur J Immunol; 2002 Aug; 32(8):2179-87. PubMed ID: 12209630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intracellular events in T lymphocyte's activation].
    Cianga C; Cianga P
    Rev Med Chir Soc Med Nat Iasi; 2002; 107(2):229-34. PubMed ID: 12638265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linking molecular and cellular events in T-cell activation and synapse formation.
    Krogsgaard M; Huppa JB; Purbhoo MA; Davis MM
    Semin Immunol; 2003 Dec; 15(6):307-15. PubMed ID: 15001169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitopes of the class I major histocompatibility complex (MHC-I) recognized in the syngeneic or allogeneic context predominantly linked to antigenic peptide loading to its binding groove.
    Nguyen van Binh P; Duc HT
    Clin Exp Immunol; 2006 Aug; 145(2):372-9. PubMed ID: 16879259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.